<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>NewsTin - Patients</title>
    <link>http://www.newstin.com/us/patients</link>
    <description>Global Social News Platform</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Vitamin D deficiency linked to breast cancer in new study</title>
      <link>http://www.newstin.com/tag/us/57521970</link>
      <description>Medical studies have shown a link between vitamin D and various forms of cancer WASHINGTON (AFP) - Women deficient in vitamin D at the time of a breast cancer diagnosis are more likely to die or see the tumor spread, a Canadian study published in the United States has shown. "We were concerned to...</description>
      <pubDate>Fri, 16 May 2008 09:51:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57521970</guid>
      <dc:date>2008-05-16T09:51:00Z</dc:date>
    </item>
    <item>
      <title>Cancer Research Group Releases Data</title>
      <link>http://www.newstin.com/tag/us/57485100</link>
      <description>To curtail data leaks that can affect drugmakers' stock prices, the American Society of Clinical Oncology discloses trial outcomes before its annual meeting Studies of drugs that may stop the spread of many cancers—vaccines for brain tumors, treatments that prevent bone metastases, vitamins that...</description>
      <pubDate>Fri, 16 May 2008 04:01:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57485100</guid>
      <dc:date>2008-05-16T04:01:00Z</dc:date>
    </item>
    <item>
      <title>Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System (PR Newswire)</title>
      <link>http://www.newstin.com/tag/us/57515847</link>
      <description>Friday May 16, 1:02 am ET - New Device Designed to Provide Fast, Safe and Secure Vessel Closure Following Catheterization Procedures ABBOTT PARK, Illinois, May 16 /PRNewswire/ -- Abbott today announced the launch of the StarClose® SE Vascular Closure System, a next-generation vessel closure...</description>
      <pubDate>Fri, 16 May 2008 09:27:17 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57515847</guid>
      <dc:date>2008-05-16T09:27:17Z</dc:date>
    </item>
    <item>
      <title>Study likely spells end for anti-bleeding drug</title>
      <link>http://www.newstin.com/tag/us/57502101</link>
      <description>by Linda A. Johnson Associated Press An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs. Bayer AG, the maker of the drug Trasylol, said...</description>
      <pubDate>Fri, 16 May 2008 08:00:22 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57502101</guid>
      <dc:date>2008-05-16T08:00:22Z</dc:date>
    </item>
    <item>
      <title>NHS Electronic Patient Record System Will Not Reach Trusts Until 2014</title>
      <link>http://www.newstin.com/tag/us/57484202</link>
      <description>A new electronic system for NHS patients' records will not be introduced before 2014 at the earliest - four years later than planned. The government is spending £12.7bn on the IT programme, which will create a centralised electronic medical record system for 50 million patients. An online "choose...</description>
      <pubDate>Fri, 16 May 2008 05:13:04 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57484202</guid>
      <dc:date>2008-05-16T05:13:04Z</dc:date>
    </item>
    <item>
      <title>Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients With Advanced...</title>
      <link>http://www.newstin.com/tag/us/57487356</link>
      <description>WOODCLIFF LAKE, N.J., May 15 /PRNewswire/ -- The investigational chemotherapeutic agent eribulin mesylate (E7389) demonstrated activity in a heavily pretreated population of women with locally advanced or metastatic breast cancer, according to results of a multi-center Phase II clinical trial.</description>
      <pubDate>Fri, 16 May 2008 05:00:06 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57487356</guid>
      <dc:date>2008-05-16T05:00:06Z</dc:date>
    </item>
    <item>
      <title>Study: Women increasingly opt for mastectomy</title>
      <link>http://www.newstin.com/tag/us/57508729</link>
      <description>More breast cancer patients are undergoing mastectomies, reversing a trend in which women were choosing less extensive surgeries that let them keep their breasts, a new study suggests. The change appears to be driven by the increased use of MRIs, or magnetic resonance imaging, according to...</description>
      <pubDate>Fri, 16 May 2008 05:56:56 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57508729</guid>
      <dc:date>2008-05-16T05:56:56Z</dc:date>
    </item>
    <item>
      <title>DMC plans to build pediatric center</title>
      <link>http://www.newstin.com/tag/us/57484487</link>
      <description>Christina Rogers / The Detroit News The Detroit Medical Center unveiled plans Thursday to build a new $34 million Children's Hospital Pediatric Center across the street from the existing hospital, expanding the footprint of the downtown campus for the first time in more than 30 years and adding...</description>
      <pubDate>Fri, 16 May 2008 05:16:50 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57484487</guid>
      <dc:date>2008-05-16T05:16:50Z</dc:date>
    </item>
    <item>
      <title>ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With...</title>
      <link>http://www.newstin.com/tag/us/57482211</link>
      <description>Posted on: Thursday, 15 May 2008, 21:00 CDT INDIANAPOLIS, May 15 /PRNewswire-FirstCall/ -- Lung cancer patients whose histology is factored into treatment decisions may fare better as a result, according to data from a pivotal non-small cell lung cancer (NSCLC) clinical trial. "The data presented...</description>
      <pubDate>Fri, 16 May 2008 02:00:06 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57482211</guid>
      <dc:date>2008-05-16T02:00:06Z</dc:date>
    </item>
    <item>
      <title>Eisai's Commitment to Oncology Demonstrated By Clinical Data to Be Presented at ASCO Annual Meeting</title>
      <link>http://www.newstin.com/tag/us/57487434</link>
      <description>WOODCLIFF LAKE, N.J., May 15 /PRNewswire/ -- Eisai Corporation of North America announced today that results from 16 clinical data abstracts about compounds in the company's oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th...</description>
      <pubDate>Fri, 16 May 2008 05:00:05 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57487434</guid>
      <dc:date>2008-05-16T05:00:05Z</dc:date>
    </item>
  </channel>
</rss>

